Pamela Sue Horst, MD | |
301 Prospect Ave, Palliative Care, Syracuse, NY 13203 | |
(315) 448-5175 | |
(315) 448-3557 |
Full Name | Pamela Sue Horst |
---|---|
Gender | Female |
Speciality | Family Medicine - Hospice And Palliative Medicine |
Location | 301 Prospect Ave, Syracuse, New York |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1033129721 | NPI | - | NPPES |
00832393 | Medicaid | NY |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 137793-1 (New York) | Secondary |
207QH0002X | Family Medicine - Hospice And Palliative Medicine | 137793-1 (New York) | Primary |
Entity Name | St Josephs Hospital Health Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1508815333 PECOS PAC ID: 9234043324 Enrollment ID: O20031113000400 |
News Archive
The withdrawal of donepezil from patients with Alzheimer's disease as they reach the moderate-to-severe stages of the disease doubles their risk of being placed in a nursing home within the first 12 months, secondary analysis of the DOMINO-AD trial indicates.
Keryx Biopharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for KRX-0401 (perifosine), the Company's novel, potentially first-in-class, oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase (PI3K) pathway, for the treatment of refractory advanced colorectal cancer.
Impax Laboratories, Inc. today confirms that it has initiated a challenge of patents listed by Shire Development Inc. in connection with INTUNIVTM (guanfacine hydrochloride), 4 mg.
ViroPharma Incorporated and Idis, the global leader in developing long-term strategic solutions to therapeutic access, today announced that the two companies have partnered to facilitate access to certain ViroPharma products through a named patient program (NPP). ViroPharma's NPP, developed and managed by Idis, will allow international healthcare professionals to prescribe certain products to individual patients until the time that approval is sought in local countries.
Many people do not get enough vitamin D. Brittle bones and an increased risk of respiratory diseases can be the result of a vitamin D deficiency.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Pamela Sue Horst, MD 301 Prospect Ave, Palliative Care, Syracuse, NY 13203 Ph: (315) 448-5175 | Pamela Sue Horst, MD 301 Prospect Ave, Palliative Care, Syracuse, NY 13203 Ph: (315) 448-5175 |
News Archive
The withdrawal of donepezil from patients with Alzheimer's disease as they reach the moderate-to-severe stages of the disease doubles their risk of being placed in a nursing home within the first 12 months, secondary analysis of the DOMINO-AD trial indicates.
Keryx Biopharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for KRX-0401 (perifosine), the Company's novel, potentially first-in-class, oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase (PI3K) pathway, for the treatment of refractory advanced colorectal cancer.
Impax Laboratories, Inc. today confirms that it has initiated a challenge of patents listed by Shire Development Inc. in connection with INTUNIVTM (guanfacine hydrochloride), 4 mg.
ViroPharma Incorporated and Idis, the global leader in developing long-term strategic solutions to therapeutic access, today announced that the two companies have partnered to facilitate access to certain ViroPharma products through a named patient program (NPP). ViroPharma's NPP, developed and managed by Idis, will allow international healthcare professionals to prescribe certain products to individual patients until the time that approval is sought in local countries.
Many people do not get enough vitamin D. Brittle bones and an increased risk of respiratory diseases can be the result of a vitamin D deficiency.
› Verified 5 days ago
Amy Elizabeth Roy, NP Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1000 E Genesee St, Suite 300, Syracuse, NY 13210 Phone: 315-471-1044 Fax: 315-474-4312 | |
Andrew Paul Aiken, FNP Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 800 Irving Ave, Va Medical Center Outpatient Cardiology, Syracuse, NY 13210 Phone: 315-425-4400 | |
Amogechukwu N Okonkwo, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 819 S Salina St, Syracuse, NY 13202 Phone: 315-476-7921 Fax: 315-475-1448 | |
Kevin E Gaskin, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 750 E Adams St, Syracuse, NY 13210 Phone: 315-464-4363 Fax: 315-464-8690 | |
Brigitte Mcgrath, Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 847 James St, Syracuse, NY 13203 Phone: 315-471-1184 | |
Matthew Micco, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 301 Prospect Ave, Syracuse, NY 13203 Phone: 315-448-5536 |